Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that it will be attending the annual European Heart Rhythm Association (EHRA) conference in Paris, France from ...
An acute pulmonary embolism occurs when a blood clot blocks one or more vessels in the lung. In patients at moderate or high ...
Pulse Biosciences (PLSE) highlights promising AFib catheter data and IDE-cleared pivotal trial progress—plus thyroid ...
Mermaid Medical Group announced that the company’s Angel catheter has received European CE Mark approval for the prevention ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation ...
InterVene, Inc., a privately held medical device company advancing interventional care for venous disease, today announced the successful completion of 30 cases using the Recana(R) Thrombectomy ...
A nationwide clinical RCT trial led by Dr. Kazumi Kimura at Kumamoto University Hospital has found that adding catheter ...
The FDA granted Irvine-based Toro Neurovascular’s Toro 88 Superbore Catheter 510(k) clearance earlier for the treatment of ...
Outcomes for PE are better with ultrasound-facilitated, catheter-directed fibrinolysis plus anticoagulation vs anticoagulation alone.
Zeus, a global leader in advanced polymer solutions and catheter manufacturing, announced a partnership with Chamfr to make ...
Catheter Precision plans to divest its cardiac AP business, including LockeT and VIVO devices, to focus on aviation after ...
Zeus expands access to catheter components through Chamfr marketplace Over 100 Zeus liner and heat shrink components will now be available Zeus says its partnership with Chamfr makes more than 100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results